The Madison Clinical Conference will be rescheduled for October 2020.
According to the National Institutes of Health (NIH), approximately 23.5 million (7.2%) Americans have an autoimmune disease. However, the American Autoimmune Related Diseases Association (AARDA) estimates that 50 million Americans suffer from an autoimmune disease. This discrepancy may be due to the NIH statistics only including 24 diseases for which epidemiology studies are available. The estimated annual direct health care costs for autoimmune diseases are $100 billion which is 40% higher than direct costs associated with cancers. According to AARDA, the Department of Health and Human Services’ Office of Women’s Health states that autoimmune diseases are the most requested health topic by callers to the organization’s information center. Given the impact of autoimmune diseases on the US healthcare system, the goal of the 2020 Madison Clinical Conference is to provide updates and stir conversation around diagnosis, new and emerging treatments and disease management for common autoimmune diseases.
Developed & Conducted by the Division of Pharmacy Professional Development, School of Pharmacy, University of Wisconsin-Madison.